Simulated haemodynamic parameters and different infusion set-up affect drug delivery during syringe pump change over: A bench-top study in a laboratory setting.

Backflow Bolus CVP Changeover Displacement Infusion Needle-free connector Syringe pump

Journal

Intensive & critical care nursing
ISSN: 1532-4036
Titre abrégé: Intensive Crit Care Nurs
Pays: Netherlands
ID NLM: 9211274

Informations de publication

Date de publication:
16 Oct 2024
Historique:
received: 05 07 2024
revised: 12 09 2024
accepted: 09 10 2024
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 17 10 2024
Statut: aheadofprint

Résumé

Infusion therapy is widely used in clinical settings, particularly in intensive care units. to explore the influence of simulated cardiac output on "bolus" or "backflow" events that can occur during syringe pump changeover, considering several factors that have been previously outlined in published research. Syringe infusion pumps are commonly used for precise continuous intravenous drug delivery. Syringe pump changeover can be a challenging procedure. Bench-top study in a laboratory setting. An extracorporeal circuit was used to simulate a cardiac output of 5 l/min. The following variables were used: three levels of vertical position of the syringe pump (-50 cm, 0, +50 cm), three levels of Central Venous Pressure (-5, 10, and 15 mmHg), presence/absence of carrier infusion (5 ml/h), and presence/absence of a needle-free connector between the syringe and extension line. A total of 108 syringe pump changes were performed with different combinations of the investigated variables. The mean time for syringe pump changeover was equal to 9.48 ± 2.45 s and the overall fluid displacement was 8 ± 40 µL (microlitres) (range, -262-156 µL). The CVP level and vertical position of the pump always statistically affected the overall displacement during syringe pump changeover. When a second infusion with an equal velocity rate to that of a syringe pump infusion is present in the same lumen, the presence of a needle-free device reduces the overall volume of displacement. Syringe pump changeover can be a critical moment for patients when vasoactive drugs are administered. In a simulated environment with a cardiac output of 5 L/min, the CVP level and vertical position of the syringe pump generated bolus or backflow events during the syringe pump changeover. The application of carrier infusion appeared to intensify these phenomena. Employing a neutral, needle-free system can potentially aid in reducing the development of boluses or backflows.

Sections du résumé

BACKGROUND BACKGROUND
Infusion therapy is widely used in clinical settings, particularly in intensive care units.
AIM OBJECTIVE
to explore the influence of simulated cardiac output on "bolus" or "backflow" events that can occur during syringe pump changeover, considering several factors that have been previously outlined in published research. Syringe infusion pumps are commonly used for precise continuous intravenous drug delivery. Syringe pump changeover can be a challenging procedure.
METHODS METHODS
Bench-top study in a laboratory setting. An extracorporeal circuit was used to simulate a cardiac output of 5 l/min. The following variables were used: three levels of vertical position of the syringe pump (-50 cm, 0, +50 cm), three levels of Central Venous Pressure (-5, 10, and 15 mmHg), presence/absence of carrier infusion (5 ml/h), and presence/absence of a needle-free connector between the syringe and extension line.
RESULTS RESULTS
A total of 108 syringe pump changes were performed with different combinations of the investigated variables. The mean time for syringe pump changeover was equal to 9.48 ± 2.45 s and the overall fluid displacement was 8 ± 40 µL (microlitres) (range, -262-156 µL). The CVP level and vertical position of the pump always statistically affected the overall displacement during syringe pump changeover. When a second infusion with an equal velocity rate to that of a syringe pump infusion is present in the same lumen, the presence of a needle-free device reduces the overall volume of displacement.
CONCLUSIONS CONCLUSIONS
Syringe pump changeover can be a critical moment for patients when vasoactive drugs are administered.
IMPLICATIONS FOR CLINICAL PRACTICE CONCLUSIONS
In a simulated environment with a cardiac output of 5 L/min, the CVP level and vertical position of the syringe pump generated bolus or backflow events during the syringe pump changeover. The application of carrier infusion appeared to intensify these phenomena. Employing a neutral, needle-free system can potentially aid in reducing the development of boluses or backflows.

Identifiants

pubmed: 39418877
pii: S0964-3397(24)00246-5
doi: 10.1016/j.iccn.2024.103861
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103861

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alberto Lucchini (A)

Direction of Health and Social Professions - Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; General Adult and Pediatric Intensive Care Unit Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy. Electronic address: alberto.lucchini@unimib.it.

Stefano Elli (S)

Direction of Health and Social Professions - Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; Vascular Access Team, Fondazione IRCCS San Gerardo dei Tintori - Monza, Italy. Electronic address: stefano.elli@unimib.it.

Alessia Burgazzi (A)

Neurosurgey - Spedali Civili Di Brescia, Brescia, Italy. Electronic address: a.burgazzi@campus.unimib.it.

Laura Malvestuto Grilli (L)

General Adult and Pediatric Intensive Care Unit Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy. Electronic address: laura.malvestutogrilli@irccs-sangerardo.it.

Claudia Pes (C)

Emergency Department, Asst Bergamo Ovest, Treviglio, Italy. Electronic address: c.pes1@campus.unimib.it.

Katia Ferrari (K)

General Adult and Pediatric Intensive Care Unit Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy. Electronic address: katia.ferrari@irccs-sangerardo.it.

Letizia Fumagalli (L)

General Adult and Pediatric Intensive Care Unit Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy. Electronic address: letizia.fumagalli@irccs-sangerardo.it.

Chiara Fiorillo (C)

General Intensive Care Unit, Azienda Ospedaliera Policlinico di Modena, Italy. Electronic address: fiorillo.chiara@aou.mo.it.

Marco Giani (M)

General Adult and Pediatric Intensive Care Unit Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy. Electronic address: marco.giani@unimib.it.

Emanuele Rezoagli (E)

University of Milano-Bicocca and Department of Emergency and Intensive Care Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. Electronic address: emanuele.rezoagli@unimib.it.

Classifications MeSH